English中文

Offstream
news



Changes

  1. Bloomington-based HealthPartners announces that they are seeking 1,500 patients for the phase 3 trails for AstraZeneca.
  2. Bloomington-based HealthPartners announces that they are seeking 1,500 patients for the phase 3 trials for AstraZeneca.
  3. Bloomington-based HealthPartners announces that they are seeking 1,500 patients for the phase 3 trials for AstraZeneca's COVID-19 vaccine.

Related